ALPROLIX®: the first EHL FIX
WITH >10 years OF REAL-WORLD EXPERIENCE1–3
Click to Explore the BODY of ALPROLIX evidence
USA flag icon Canada flag icon Multi-centre qualitative survey UK flag icon SHL switch Europe flag icon European chart review Whole-country switch Ireland flag icon Previous FIX switch France flag icon
Scalpel icon Surgery Syringe icon On-demand to prophylaxis Clock icon Pooled longitudinal analysis

References

  1. ALPROLIX Package Insert. FDA.
    Revised October 2020.
  2. IDELVION Package Insert. FDA. June 2023.
  3. REBINYN Package Insert. FDA. June 2017.
  4. Shapiro AD, et al. Blood Adv. 2023;7:3049–3057.
  5. Shapiro AD, et al. Blood Adv. 2023;7:
    3049–3057(Suppl).
  6. Chambost H, et al. EAHAD 2023 Poster PO068.
  7. O’Donovan M, et al. Haemophilia. 2021;27:618–625.
  8. O’Donovan M, et al. Res Pract Thromb Haemost. 2021;5:e12602.
  1. Wall C, et al. UKHCDO poster presented at
    EAHAD 2020.
  2. Malec LM, et al. ASH 2019 Abstract 2407.
  3. Funding E, et al. Adv Ther. 2023;40:3770–3783.
  4. O’Donovan M, et al. Haemophilia. 2021;27(6):
    e690–e697.
  5. Shapiro A, et al. Haemophilia. 2020;26(6):975–983.
  6. ALPROLIX UK Summary of Product
    Characteristics. June 2021.




Back Safety information References
Multi-centre qualitative survey SHL switch European chart review Whole-country switch Previous FIX switch Surgery On-demand to prophylaxis Pooled longitudinal analysis